Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Although motor disturbances parallel the course of dementia, worsening both quality of life and social costs, the pathogenesis remains still unclear. Objective: Through the combination of cerebrospinal fluid (CSF) biomarkers assessment and transcranial magnetic stimulation (TMS) protocols, here we provided a cross-sectional study to understand pathogenic mechanisms of Alzheimer's disease (AD)-related early motor disturbances. Methods: The motor phenotype, as defined with Unified Parkinson's Disease Rating Scale (UPDRS) part 2-3, Rating Scale for Gait Evaluation in Cognitive Deterioration (RSEGCD) and Tinetti scale, together with CSF profile of amyloid-β 42 (Aβ 42), total-tau, and phosphorylated-tau were determined in 37 AD patients and compared to 18 patients with vascular dementia (VaD). A TMS protocol of short afferent inhibition (SAI) was further applied on a subset of AD patients. Clinical, biochemical, and neurophysiological data were then compared and correlated in order to find significant associations. Results: AD patients exhibited subtle locomotor impairment and slight extrapyramidal signs. Main motor features (UPDRS part 3, RSGECD, and Tinetti scale scores) correlate with Aβ 42 levels but not with t-tau and p-tau. AD patients also presented SAI impairment directly related to UPDRS part 3 score and Aβ 42 levels. Motor disturbances of VaD group did not differ statistically from AD and did not correlate with CSF biomarkers. Conclusions: The association of motor disturbances with low Aβ 42 CSF levels and individual SAI suggests that amyloid-mediated degeneration of cholinergic system may account for early AD-related motor impairment, providing interesting insights either for frailty stratification of patients or personalized therapies.

Original languageEnglish
Pages (from-to)525-532
Number of pages8
JournalJournal of Alzheimer's Disease
Volume64
Issue number2
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Amyloid
Cholinergic Agents
Alzheimer Disease
Cerebrospinal Fluid
Parkinson Disease
Vascular Dementia
Transcranial Magnetic Stimulation
Biomarkers
Gait
Dementia
Cross-Sectional Studies
Quality of Life
Phenotype
Costs and Cost Analysis
Inhibition (Psychology)

Keywords

  • Alzheimer's disease
  • amyloid
  • cholinergic
  • frailty
  • gait
  • locomotor
  • vascular dementia

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease. / Schirinzi, Tommaso; Di Lorenzo, Francesco; Sancesario, Giulia Maria; Di Lazzaro, Giulia; Ponzo, Viviana; Pisani, Antonio; Mercuri, Nicola Biagio; Koch, Giacomo; Martorana, Alessandro.

In: Journal of Alzheimer's Disease, Vol. 64, No. 2, 01.01.2018, p. 525-532.

Research output: Contribution to journalArticle

@article{8e9fb6248fea4f19821327f3060449e6,
title = "Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease",
abstract = "Background: Although motor disturbances parallel the course of dementia, worsening both quality of life and social costs, the pathogenesis remains still unclear. Objective: Through the combination of cerebrospinal fluid (CSF) biomarkers assessment and transcranial magnetic stimulation (TMS) protocols, here we provided a cross-sectional study to understand pathogenic mechanisms of Alzheimer's disease (AD)-related early motor disturbances. Methods: The motor phenotype, as defined with Unified Parkinson's Disease Rating Scale (UPDRS) part 2-3, Rating Scale for Gait Evaluation in Cognitive Deterioration (RSEGCD) and Tinetti scale, together with CSF profile of amyloid-β 42 (Aβ 42), total-tau, and phosphorylated-tau were determined in 37 AD patients and compared to 18 patients with vascular dementia (VaD). A TMS protocol of short afferent inhibition (SAI) was further applied on a subset of AD patients. Clinical, biochemical, and neurophysiological data were then compared and correlated in order to find significant associations. Results: AD patients exhibited subtle locomotor impairment and slight extrapyramidal signs. Main motor features (UPDRS part 3, RSGECD, and Tinetti scale scores) correlate with Aβ 42 levels but not with t-tau and p-tau. AD patients also presented SAI impairment directly related to UPDRS part 3 score and Aβ 42 levels. Motor disturbances of VaD group did not differ statistically from AD and did not correlate with CSF biomarkers. Conclusions: The association of motor disturbances with low Aβ 42 CSF levels and individual SAI suggests that amyloid-mediated degeneration of cholinergic system may account for early AD-related motor impairment, providing interesting insights either for frailty stratification of patients or personalized therapies.",
keywords = "Alzheimer's disease, amyloid, cholinergic, frailty, gait, locomotor, vascular dementia",
author = "Tommaso Schirinzi and {Di Lorenzo}, Francesco and Sancesario, {Giulia Maria} and {Di Lazzaro}, Giulia and Viviana Ponzo and Antonio Pisani and Mercuri, {Nicola Biagio} and Giacomo Koch and Alessandro Martorana",
year = "2018",
month = "1",
day = "1",
doi = "10.3233/JAD-171166",
language = "English",
volume = "64",
pages = "525--532",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease

AU - Schirinzi, Tommaso

AU - Di Lorenzo, Francesco

AU - Sancesario, Giulia Maria

AU - Di Lazzaro, Giulia

AU - Ponzo, Viviana

AU - Pisani, Antonio

AU - Mercuri, Nicola Biagio

AU - Koch, Giacomo

AU - Martorana, Alessandro

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Although motor disturbances parallel the course of dementia, worsening both quality of life and social costs, the pathogenesis remains still unclear. Objective: Through the combination of cerebrospinal fluid (CSF) biomarkers assessment and transcranial magnetic stimulation (TMS) protocols, here we provided a cross-sectional study to understand pathogenic mechanisms of Alzheimer's disease (AD)-related early motor disturbances. Methods: The motor phenotype, as defined with Unified Parkinson's Disease Rating Scale (UPDRS) part 2-3, Rating Scale for Gait Evaluation in Cognitive Deterioration (RSEGCD) and Tinetti scale, together with CSF profile of amyloid-β 42 (Aβ 42), total-tau, and phosphorylated-tau were determined in 37 AD patients and compared to 18 patients with vascular dementia (VaD). A TMS protocol of short afferent inhibition (SAI) was further applied on a subset of AD patients. Clinical, biochemical, and neurophysiological data were then compared and correlated in order to find significant associations. Results: AD patients exhibited subtle locomotor impairment and slight extrapyramidal signs. Main motor features (UPDRS part 3, RSGECD, and Tinetti scale scores) correlate with Aβ 42 levels but not with t-tau and p-tau. AD patients also presented SAI impairment directly related to UPDRS part 3 score and Aβ 42 levels. Motor disturbances of VaD group did not differ statistically from AD and did not correlate with CSF biomarkers. Conclusions: The association of motor disturbances with low Aβ 42 CSF levels and individual SAI suggests that amyloid-mediated degeneration of cholinergic system may account for early AD-related motor impairment, providing interesting insights either for frailty stratification of patients or personalized therapies.

AB - Background: Although motor disturbances parallel the course of dementia, worsening both quality of life and social costs, the pathogenesis remains still unclear. Objective: Through the combination of cerebrospinal fluid (CSF) biomarkers assessment and transcranial magnetic stimulation (TMS) protocols, here we provided a cross-sectional study to understand pathogenic mechanisms of Alzheimer's disease (AD)-related early motor disturbances. Methods: The motor phenotype, as defined with Unified Parkinson's Disease Rating Scale (UPDRS) part 2-3, Rating Scale for Gait Evaluation in Cognitive Deterioration (RSEGCD) and Tinetti scale, together with CSF profile of amyloid-β 42 (Aβ 42), total-tau, and phosphorylated-tau were determined in 37 AD patients and compared to 18 patients with vascular dementia (VaD). A TMS protocol of short afferent inhibition (SAI) was further applied on a subset of AD patients. Clinical, biochemical, and neurophysiological data were then compared and correlated in order to find significant associations. Results: AD patients exhibited subtle locomotor impairment and slight extrapyramidal signs. Main motor features (UPDRS part 3, RSGECD, and Tinetti scale scores) correlate with Aβ 42 levels but not with t-tau and p-tau. AD patients also presented SAI impairment directly related to UPDRS part 3 score and Aβ 42 levels. Motor disturbances of VaD group did not differ statistically from AD and did not correlate with CSF biomarkers. Conclusions: The association of motor disturbances with low Aβ 42 CSF levels and individual SAI suggests that amyloid-mediated degeneration of cholinergic system may account for early AD-related motor impairment, providing interesting insights either for frailty stratification of patients or personalized therapies.

KW - Alzheimer's disease

KW - amyloid

KW - cholinergic

KW - frailty

KW - gait

KW - locomotor

KW - vascular dementia

UR - http://www.scopus.com/inward/record.url?scp=85049184848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049184848&partnerID=8YFLogxK

U2 - 10.3233/JAD-171166

DO - 10.3233/JAD-171166

M3 - Article

AN - SCOPUS:85049184848

VL - 64

SP - 525

EP - 532

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -